Although they are not favorite objects to share personal experiences, urinary incontinence and medical problems regarding urination are extremely common.
Adult women are particularly sensitive. It is estimated that there are about half afflicted To some extent, along with the prevalence of violent with age. Men are too threatened.
With older populations They grow In various industrialized countries, the treatment and management of those conditions also turned out to be more and dearer. Global diaper expenses for adults and other urinary incontinence products are expected reception $ 9.7 billion in 2025 and is consistently growing in the coming years. Treatment equipment market, currently estimated It is expected that it would increase even faster for over $ 4 billion a yr.
To sum up: in the case of a topic that folks mostly avoid moving free conversation, urinary incontinence is a huge addressed market. And the founders and investors of the startup took attention.
Lots of financing turnover
On Crunchbase dataA dozen or so firms related to urinary incontinence and urine health collected financial rounds in 2024 and 2025. Our sample Kohort, listed below, has raised over $ 500 million so far.
This is a diverse offer, each in terms of geography and specialization, although most are startups of medical devices.
In this area, the latest large round hit StomachStENT developing a stent to relieve the lower symptoms of urinary tract associated with mild prostate growth (BPH), non -cancerous enlargement of the prostate gland that happens as men aged. This week, the company based in Dublin finished $ 80 billion in financing of the B series.
Neuromodulation
As for the total financing so far, the leading name on our list is Medical failureCreator of neuromodulation therapy for urinary incontinence, an excessive symptom of bladder says Affects 1 in 5 women in the USA. Neusper based in San Jose has collected $ 135 million in well -known funding, on Crunchbase data.
Neusper is also developing on the commercialization front. This summer he received the approval of the FDA for the miniaturized neurostimulator implant, which is said to be effective in reducing or eliminating urinary leaks.
Valencia technologieswith its registered office in Valencia, California, he also uses neuromodulation technology to treat bladder dysfunction. A 14-year-old company collected up to $ 35 million in financing at the starting of this yr to proceed the commercialization of Ecoin, a neurostimulator of the size of the coin implanted under the skin near the ankle. The device ensures periodic stimulation of the tibial nerve to reduce urinary incontinence episodes.
Grain and early stage
We also see smaller rounds on the seeds and the early stage of startups dealing with urinary incontinence.
Biennial Axena HealthFor example, last yr, he closed a series of 9.4 million dollars for a system for women to train and strengthen the pelvic floor muscles. And based on minnesota Platform Closed last yr to finance seeds for treatment of urinary incontinence and weakened the pelvic floor muscles.
On the side of consumer products, Hazel He also raised a lot of seed financing on Crunchbase datato scale your offer of disposable tight panties.
A brand new reason not to talk about urinary incontinence
Although it would inevitably take the time for the current pipeline of financed startups on so much scaling to measure the problems they solve measuring, he hopes that he’ll eventually win.
If every thing works exceptionally well, it is expected that urinary incontinence will still be the subject that folks do not say much about. However, this can not be because they are embarrassed, but moderately because they do not have to worry about it.